|
1
|
Zhang W, Zhang Y and Xi S: Upregulation of
lncRNA HAGLROS enhances the development of nasopharyngeal carcinoma
via modulating miR-100/ATG14 axis-mediated PI3K/AKT/mTOR signals.
Artif Cells Nanomed Biotechnol. 47:3043–3052. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fan C, Tang Y, Wang J, Wang Y, Xiong F,
Zhang S, Li X, Xiang B, Wu X, Guo C, et al: Long non-coding RNA
LOC284454 promotes migration and invasion of nasopharyngeal
carcinoma via modulating the Rho/Rac signaling pathway.
Carcinogenesis. 40:380–391. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kang M, Zhou P, Li G, Yan H, Feng G, Liu
M, Zhu J and Wang R: Validation of the 8th edition of the UICC/AJCC
staging system for nasopharyngeal carcinoma treated with
intensity-modulated radiotherapy. Oncotarget. 8:70586–70594. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wei F, Wu Y, Tang L, He Y, Shi L, Xiong F,
Gong Z, Guo C, Li X, Liao Q, et al: BPIFB1 (LPLUNC1) inhibits
migration and invasion of nasopharyngeal carcinoma by interacting
with VTN and VIM. Br J Cancer. 118:233–247. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kamran SC, Riaz N and Lee N:
Nasopharyngeal carcinoma. Surg Oncol Clin North Am. 24:547–561.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim ED and Sung S: Long noncoding RNA:
Unveiling hidden layer of gene regulatory networks. Trends Plant
Sci. 17:16–21. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kong X, Duan Y, Sang Y, Li Y, Zhang H,
Liang Y, Liu Y, Zhang N and Yang Q: LncRNA-CDC6 promotes breast
cancer progression and function as ceRNA to target CDC6 by sponging
microRNA-215. J Cell Physiol. 234:9105–9117. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang J, Su Z, Lu S, Fu W, Liu Z, Jiang X
and Tai S: LncRNA HOXA-AS2 and its molecular mechanisms in human
cancer. Clin Chim Acta. 485:229–233. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chan JJ and Tay Y: Noncoding RNA:RNA
regulatory networks in cancer. Int J Mol Sci. 19:13102018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Z, Feng L, Liu P and Duan W: ANRIL
promotes chemoresistance via disturbing expression of ABCC1 by
regulating the expression of Let-7a in colorectal cancer. Biosci
Rep. 38:BSR201806202018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cao C, Zhou S and Hu J: Long noncoding RNA
MAGI2-AS3/miR-218-5p/GDPD5/SEC61A1 axis drives cellular
proliferation and migration and confers cisplatin resistance in
nasopharyngeal carcinoma. Int Forum Allergy Rhinol. 10:1012–1023.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cui Z, Pu T, Zhang Y, Wang J and Zhao Y:
Long non-coding RNA LINC00346 contributes to cisplatin resistance
in nasopharyngeal carcinoma by repressing miR-342-5p. Open Biol.
10:1902862020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li H, Huang J, Yu S and Lou Z: Long
non-coding RNA DLEU1 Up-regulates BIRC6 expression by competitively
sponging miR-381-3p to promote cisplatin resistance in
nasopharyngeal carcinoma. Onco Targets Ther. 13:2037–2045. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Q, Zhang W and Hao S: LncRNA CCAT1
modulates the sensitivity of paclitaxel in nasopharynx cancers
cells via miR-181a/CPEB2 axis. Cell Cycle. 16:795–801. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lenkala D, LaCroix B, Gamazon ER, Geeleher
P, Im HK and Huang RS: The impact of microRNA expression on
cellular proliferation. Hum Genet. 133:931–938. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tufekci KU, Meuwissen RL and Genc S: The
role of microRNAs in biological processes. Methods Mol Biol.
1107:15–31. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mihanfar A, Fattahi A and Nejabati HR:
MicroRNA-mediated drug resistance in ovarian cancer. J Cell
Physiol. 234:3180–3191. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van Jaarsveld MT, Helleman J, Berns EM and
Wiemer EA: MicroRNAs in ovarian cancer biology and therapy
resistance. Int J Biochem Cell Biol. 42:1282–1290. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao Y, Wang P and Wu Q: miR-1278
sensitizes nasopharyngeal carcinoma cells to cisplatin and
suppresses autophagy via targeting ATG2B. Mol Cell Probes.
53:1015972020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yuan TZ, Zhang HH, Lin XL, Yu JX, Yang QX,
Liang Y, Deng J, Huang LJ and Zhang XP: microRNA-125b reverses the
multidrug resistance of nasopharyngeal carcinoma cells via
targeting of Bcl-2. Mol Med Rep. 15:2223–2228. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Carey LA, Metzger R, Dees EC, Collichio F,
Sartor CI, Ollila DW, Klauber-DeMore N, Halle J, Sawyer L, Moore DT
and Graham ML: American Joint Committee on Cancer
tumor-node-metastasis stage after neoadjuvant chemotherapy and
breast cancer outcome. J Natl Cancer Inst. 97:1137–1142. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang W, Lou W, Ding B, Yang B, Lu H, Kong
Q and Fan W: A novel mRNA-miRNA-lncRNA competing endogenous RNA
triple sub-network associated with prognosis of pancreatic cancer.
Aging. 11:2610–2627. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luo H, Xu C, Le W, Ge B and Wang T: lncRNA
CASC11 promotes cancer cell proliferation in bladder cancer through
miRNA-150. J Cell Biochem. 120:13487–13493. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang J, Xie T, Zhong X, Jiang HL, Li R,
Wang BY, Huang XT, Cen BH and Yuan YW: Melatonin reverses
nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting
the Wnt/beta-catenin signaling pathway. Aging (Albany NY).
12:5423–5438. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang R, Li SW, Liu L, Yang J, Huang G and
Sang Y: TRIM11 facilitates chemoresistance in nasopharyngeal
carcinoma by activating the beta-catenin/ABCC9 axis via
p62-selective autophagic degradation of Daple. Oncogenesis.
9:452020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xue JY, Huang C, Wang W, Li HB, Sun M and
Xie M: HOXA11-AS: A novel regulator in human cancer proliferation
and metastasis. Onco Targets Ther. 11:4387–4393. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu J, Zhang Y, You Q, Fu H, Zhao X, Lu K,
Yan R and Yang D: LncRNA PTCSC3 alleviates the postoperative
distant recurrence of gastric cancer by suppression of lncRNA
HOXA11-AS. Cancer Manag Res. 12:2623–2629. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Niu X, Yang B, Liu F and Fang Q: LncRNA
HOXA11-AS promotes OSCC progression by sponging miR-98-5p to
upregulate YBX2 expression. Biomed Pharmacother. 121:1096232020.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun M, Nie F, Wang Y, Zhang Z, Hou J, He
D, Xie M, Xu L, De W, Wang Z and Wang J: LncRNA HOXA11-AS promotes
proliferation and invasion of gastric cancer by scaffolding the
chromatin modification factors PRC2, LSD1, and DNMT1. Cancer Res.
76:6299–6310. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu CH, Xiao LM, Liu Y, Chen LK, Zheng SY,
Zeng EM and Li DH: The lncRNA HOXA11-AS promotes glioma cell growth
and metastasis by targeting miR-130a-5p/HMGB2. Eur Rev Med
Pharmacol Sci. 23:241–252. 2019.PubMed/NCBI
|
|
32
|
Zhan M, He K, Xiao J, Liu F, Wang H, Xia
Z, Duan X, Huang R, Li Y, He X, et al: LncRNA HOXA11-AS promotes
hepatocellular carcinoma progression by repressing miR-214-3p. J
Cell Mol Med. 22:3758–3767. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao X, Li X, Zhou L, Ni J, Yan W, Ma R,
Wu J, Feng J and Chen P: LncRNA HOXA11-AS drives cisplatin
resistance of human LUAD cells via modulating miR-454-3p/Stat3.
Cancer Sci. 109:3068–3079. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang X, Li H and Shi J: LncRNA HOXA11-AS
promotes proliferation and cisplatin resistance of oral squamous
cell carcinoma by suppression of miR-214-3p expression. Biomed Res
Int. 2019:86451532019.PubMed/NCBI
|
|
35
|
Xie C, Chen B, Wu B, Guo J and Cao Y:
LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in
osteosarcoma by regulating miR-212-3p/FOXA1 axis. Biomed
Pharmacother. 97:1645–1653. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Luo H, Yang L, Liu C, Wang X, Dong Q, Liu
L and Wei Q: TMPO-AS1/miR-98-5p/EBF1 feedback loop contributes to
the progression of bladder cancer. Int J Biochem Cell Biol.
122:1057022020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yahya SM and Yahya SM: The effect of
miR-98 and miR-214 on apoptotic and angiogenic pathways in
hepatocellular carcinoma HepG2 cells. Indian J Clin Biochem.
35:353–358. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Qiu K, Xie Q, Jiang S and Lin T: miR-98-5p
promotes apoptosis and inhibits migration and cell growth in
papillary thyroid carcinoma through Bax/Caspase-3 by HMGA2. J Clin
Lab Anal. 34:e230442020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cai C, Huo Q, Wang X, Chen B and Yang Q:
SNHG16 contributes to breast cancer cell migration by competitively
binding miR-98 with E2F5. Biochem Biophys Res Commun. 485:272–278.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu F, Mo Q, Wan X, Dan J and Hu H:
NEAT1/hsa-mir-98-5p/MAPK6 axis is involved in non-small-cell lung
cancer development. J Cell Biochem. 120:2836–2846. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xiang Q, Tang H, Yu J, Yin J, Yang X and
Lei X: MicroRNA-98 sensitizes cisplatin-resistant human lung
adenocarcinoma cells by up-regulation of HMGA2. Pharmazie.
68:274–281. 2013.PubMed/NCBI
|
|
42
|
Huang Y, Hong X, Hu J and Lu Q: Targeted
regulation of MiR-98 on E2F1 increases chemosensitivity of leukemia
cells K562/A02. Onco Targets Ther. 10:3233–3239. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Guo H, Chu Y, Wang L, Chen X, Chen Y,
Cheng H, Zhang L, Zhou Y, Yang FC, Cheng T, et al: PBX3 is
essential for leukemia stem cell maintenance in MLL-rearranged
leukemia. Int J Cancer. 141:324–335. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang S, Li C, Wang W and Xing C: PBX3
promotes gastric cancer invasion and metastasis by inducing
epithelial-mesenchymal transition. Oncol Lett. 12:3485–3491. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li H, Wang J, Xu F, Wang L, Sun G, Wang J
and Yang Y: By downregulating PBX3, miR-526b suppresses the
epithelial-mesenchymal transition process in cervical cancer cells.
Future Oncol. 15:1577–1591. 2019. View Article : Google Scholar : PubMed/NCBI
|
